Abstract
The diagnostic criteria of acute polyneuropathy are based on clinical, laboratory, and electrodiagnostic criteria. The clinical spectrum of Guillain–Barre syndrome (GBS) consists of acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor sensory axonal neuropathy (AMSAN), and Miller–Fisher syndrome (MFS). These heterogeneous groups of pathological entities have their own pathogenesis. In about two-thirds of the patients, GBS is preceded by infections. Campylobacter jejuni has been postulated to induce both acute motor neuropathy (AMN) and acute motor sensory neuropathy (AMSN) but can give a Miller–Fisher syndrome. In GBS, there seems a predisposition toward the proximal or nerve root regions. Central conduction times are essentially normal. The most frequently encountered abnormality early in GBS is conduction block. Such a block is present if there is a reduction in the peak-to-peak compound muscle action potential (CMAP) amplitude of more than 20%—a drop in proximal compared with distal CMAP), in the median, ulnar, and peroneal nerves.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.